What this ad does well
Naming menopause in the first line calls out a specific audience, and anyone in that stage knows right away the ad is for them. The visual is hard to scroll past: a torso in bright green shorts with the belly covered in yellow beads, with the presenter reacting in the corner, so the topic is clear before the voiceover starts. The script stacks benefits as a run of short questions (once a day, no injection, no insurance, no in-person visits), each answering a reason someone might not start. It ends by showing the state-availability screen of the intake, so the viewer sees exactly where the click goes.
What's missing
The ad names an audience but not a moment: there's nothing about what menopause weight change actually feels like day to day, so the hook relies on the visual rather than a problem in the viewer's words. It also leans on the top of the range, with the voiceover saying “up to 20%” while the on-screen footnote describes a lower trial average, and keeping proof inside its actual scope is better for trust in a health ad. The price is only in the caption. If you make one like this, open on one concrete midlife moment, keep any result claim matched to its footnote, and put the first-month price on screen before the closing intake shot.
Beat by beat
- 0-3s
A torso in green shorts with yellow beads over the belly, the presenter in the corner, and the caption about trying Wegovy for menopausal weight loss.An unusual visual and a named life stage stop the scroll and tell the right viewer this is for them.
- 3-10s
The voiceover says the pill is meant to regulate appetite and curb cravings, with on-screen notes that this was studied in animal models and isn't fully understood.It frames the mechanism the ad is pitching while carrying the required qualifiers on screen.
- 10-20s
A run of benefit lines: first FDA-approved GLP-1 pill for weight loss, once a day, no injection, no insurance, no in-person visits, fully online, followed by the up-to-20% claim with a footnote.Each line removes one reason to hesitate, in the order a cautious viewer would raise them.
- 20s-end
A start-sooner line, a prompt to take the online consultation, and the intake screen checking for licensed providers in your state.It shows the first step of the funnel so the click feels predictable.
The offer
Medication from $149/mo plus a separate membership of $39 for the first month and $149/month after, if prescribed. The price appears in the caption, not in the video.
Where it sends people
The ad lands on the Hers Wegovy consultation page, a quiz-style entry whose hero card asks right away whether the visitor already has a treatment in mind, with pill, injection or provider-recommendation answers. That matches the video's closing intake shot well. Below it, an options carousel shows a from-price per format, and the dosing schedule and FAQ answer the cost, insurance and side-effect questions this ad raises. Nothing on the page speaks to menopause specifically, so the ad's sharpest hook isn't picked up after the click. One of 53 ads in the Fluid library that land on this page.
The page it sends people to: How Hers starts its Wegovy consultation inside the page hero
Hers's Wegovy consultation page opens with the first intake question in a card over the hero, then scrolls through medication cards with "from" monthly prices, a results band, membership perks, a dosing schedule and a long FAQ. 53 ads in the Fluid library send people here, including price-led, food-noise, membership-value and creator-story ads.
How the page is built
- 01
Announcement bar and headerA single line on affordability sits above a logo-only header, so the price question gets a nod before anything else and there's no navigation to wander off into.
- 02
Hero with intake cardA full-bleed portrait with a descending line-graph overlay frames a centered card that asks whether the visitor already has a treatment in mind, answering "where do I start?" with three one-tap choices.
- 03
Options carouselHorizontal medication cards show the product, prescription and availability tags, a "from" monthly price and a safety link, answering "what are my options and what do they cost?" with pricing and eligibility fine print below.
- 04
Results bandAn outdoor photo of two women carries a headline, three check items and a frosted card with a large outcome figure, which is the page's main answer to "what could this look like for me?"
- 05
MembershipA four-photo collage (provider, app, product, smart scale) sits over five check-row perks, answering "what am I paying the membership for?"
- 06
Health-marker carouselDark cards pair data-visualization illustrations with short benefit claims and footnotes, covering what the page says treatment can involve beyond the scale.
- 07
Dosing scheduleA chart of example monthly dose increases and a numbered four-step accordion with dose pills explain how treatment eases in, answering "what happens month to month?"
- 08
FAQA long accordion covers membership, cost, options, visits, insurance, HSA, eligibility, switching and side effects, catching the practical objections that are left.
- 09
FooterDisclaimers, an app-download card with a QR code, a pharmacy certification badge and a sister-brand card close the page with trust signals and legal detail.
The first fixes we would make
- The membership fee is separate from the medication price, and that detail lives in fine print under the carousel. Put the combined monthly cost (medication plus membership) right under each "from" price, so a visitor who came from a price ad sees the number they'll actually pay before they start the intake.
- Creator-story ads send people here, but the page has no member stories or reviews to pick up that voice; the results band shows a single outcome figure instead. Add a short strip of member stories (with the same disclaimers Hers uses elsewhere) near the results band, so someone who clicked a creator's documentary finds people like that creator on the page.
Read the full breakdown of this page
Three hooks you could test
- Lead with the uncomfortable problem. “Same habits as five years ago, but your jeans don't agree?”
- Turn the benefit into a picture people get in a second. “What if your afternoon snack craving just didn't show up?”
- Call out the habit you're replacing. “No more planning your week around a clinic appointment.”
What to borrow for your brand
- Name the life stage in the opening caption (menopause, new parent, first job), so the right viewer self-selects in the first second.
- Write the benefits as a rapid run of short questions, each one answering a separate reason someone might hesitate.
- End the video on a screen recording of your first intake or signup step, so viewers know exactly what tapping leads to.
Transcript
What would happen if you tried Bogovi during menopause to regulate appetite and curb cravings? You'd get the 1st FDA approved GLP1 intil for weight loss? Clinically proven and taken only once a day? No injection needed. No insurance required, no in-person visits? Just 100% online. Women are losing up to 20% of their body weight, thanks to the one-day legal govia pill with hers. The sooner you start, the sooner you can start seeing results. Take the online consultation to get started.
Text on screen
- What would happen if you tried
- Wegovy® for menopausal weight loss
- Actor portrayal
- The effect of Wegovy was studied in animal nodeis.
- The impact of Wegory in the brain is not fully anderstood.
- The effect of Wegovy, was studied in animal models.
- The impact of Wegovy in the brain is not fully understood.
- To regulate appetite
- and curb cravings?
- The effect of Wegovy was studied in animurn
- The impact of Wegory in the brain is not fully un
- You'd get the first FDA-approved
- GLP-1 in a Pill for weight loss
- -Clinically proven" and taken
- only once a day
- *In a 71-wove citical study of Wigery
- on avg. 13.6% body-
- sight alongside diet and mercise ind
- ming result in weightre
- Sight of obesity
- * Stopping treatme
- Clinically proven* and taken
- ory ocal semagletide (25mg), adults with overweight of obesity lost
- on avg: 13.6% body weight along
- side diet and exercise. Individual results may vary, Stopping treatinent
- may result in weight regais.
- No injection needed
- No insurance required
- wegovy 1.5 mg
- No in-person visits
- Just 100% online
- Women are losing up to 20%
- of their body weight®
- People lost an average of 14% body weight
- at 64 weeks in a clinical trial of Wegovy
- *In a 71-week clinkal study
- obesity lost 220
- gwen contagletice (25mg),279% of adults with ovenweight or
- trek 6-h, alongside dist and emerg
- %. Individual results may vary.
One of 125 Hers ads in the Fluid Inspiration Library, captured from the Meta Ad Library on Oct 20, 2026. We record that an ad ran publicly, not how it performed.